Global Bioengineered Protein Drugs Market Research Report 2019

Table of Contents

Executive Summary

1 Bioengineered Protein Drugs Market Overview

• 1.1 Product Overview and Scope of Bioengineered Protein Drugs
• 1.2 Bioengineered Protein Drugs Segment by Type
  • 1.2.1 Global Bioengineered Protein Drugs Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Recombinant protein drugs
  • 1.2.3 Peptide hormones
  • 1.2.4 Vaccines
  • 1.2.5 Therapeutic enzymes
  • 1.2.6 Monoclonal antibodies
  • 1.2.7 Cytokines
  • 1.2.8 Replacement proteins
  • 1.2.9 Peptide antibiotics
  • 1.2.10 Blood products
• 1.3 Bioengineered Protein Drugs Segment by Application
  • 1.3.1 Bioengineered Protein Drugs Consumption Comparison by Application (2014-2025)
  • 1.3.2 Fractionation
  • 1.3.3 Bioreactors and microbial cell fermentation
  • 1.3.4 Genetic engineering
  • 1.3.5 Genetically modified organisms
  • 1.3.6 Pharming
  • 1.3.7 Bioengineered protein drugs produced by transgenic microorganisms, plants and animals
  • 1.3.8 Cell culture
  • 1.3.9 Others
• 1.4 Global Bioengineered Protein Drugs Market by Region
  • 1.4.1 Global Bioengineered Protein Drugs Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Bioengineered Protein Drugs Market Size
  • 1.5.1 Global Bioengineered Protein Drugs Revenue (2014-2025)
  • 1.5.2 Global Bioengineered Protein Drugs Production (2014-2025)

2 Global Bioengineered Protein Drugs Market Competition by Manufacturers

• 2.1 Global Bioengineered Protein Drugs Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Bioengineered Protein Drugs Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Bioengineered Protein Drugs Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Bioengineered Protein Drugs Production Sites, Area Served, Product Types
• 2.5 Bioengineered Protein Drugs Market Competitive Situation and Trends
  • 2.5.1 Bioengineered Protein Drugs Market Concentration Rate
  • 2.5.2 Bioengineered Protein Drugs Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Bioengineered Protein Drugs Production Market Share by Regions

• 3.1 Global Bioengineered Protein Drugs Production Market Share by Regions
• 3.2 Global Bioengineered Protein Drugs Revenue Market Share by Regions (2014-2019)
• 3.3 Global Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Bioengineered Protein Drugs Production
  • 3.4.1 North America Bioengineered Protein Drugs Production Growth Rate (2014-2019)
  • 3.4.2 North America Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Bioengineered Protein Drugs Production
  • 3.5.1 Europe Bioengineered Protein Drugs Production Growth Rate (2014-2019)
  • 3.5.2 Europe Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Bioengineered Protein Drugs Production (2014-2019)
  • 3.6.1 China Bioengineered Protein Drugs Production Growth Rate (2014-2019)
  • 3.6.2 China Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Bioengineered Protein Drugs Production (2014-2019)
  • 3.7.1 Japan Bioengineered Protein Drugs Production Growth Rate (2014-2019)
  • 3.7.2 Japan Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Bioengineered Protein Drugs Consumption by Regions

• 4.1 Global Bioengineered Protein Drugs Consumption by Regions
• 4.2 North America Bioengineered Protein Drugs Consumption (2014-2019)
• 4.3 Europe Bioengineered Protein Drugs Consumption (2014-2019)
• 4.4 China Bioengineered Protein Drugs Consumption (2014-2019)
• 4.5 Japan Bioengineered Protein Drugs Consumption (2014-2019)

5 Global Bioengineered Protein Drugs Production, Revenue, Price Trend by Type

• 5.1 Global Bioengineered Protein Drugs Production Market Share by Type (2014-2019)
• 5.2 Global Bioengineered Protein Drugs Revenue Market Share by Type (2014-2019)
• 5.3 Global Bioengineered Protein Drugs Price by Type (2014-2019)
• 5.4 Global Bioengineered Protein Drugs Production Growth by Type (2014-2019)

6 Global Bioengineered Protein Drugs Market Analysis by Applications

• 6.1 Global Bioengineered Protein Drugs Consumption Market Share by Application (2014-2019)
• 6.2 Global Bioengineered Protein Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Bioengineered Protein Drugs Business

• 7.1 Abbot
  • 7.1.1 Abbot Bioengineered Protein Drugs Production Sites and Area Served
  • 7.1.2 Bioengineered Protein Drugs Product Introduction, Application and Specification
  • 7.1.3 Abbot Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Amgen
  • 7.2.1 Amgen Bioengineered Protein Drugs Production Sites and Area Served
  • 7.2.2 Bioengineered Protein Drugs Product Introduction, Application and Specification
  • 7.2.3 Amgen Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Baxter
  • 7.3.1 Baxter Bioengineered Protein Drugs Production Sites and Area Served
  • 7.3.2 Bioengineered Protein Drugs Product Introduction, Application and Specification
  • 7.3.3 Baxter Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Bayer
  • 7.4.1 Bayer Bioengineered Protein Drugs Production Sites and Area Served
  • 7.4.2 Bioengineered Protein Drugs Product Introduction, Application and Specification
  • 7.4.3 Bayer Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Eli Lilly
  • 7.5.1 Eli Lilly Bioengineered Protein Drugs Production Sites and Area Served
  • 7.5.2 Bioengineered Protein Drugs Product Introduction, Application and Specification
  • 7.5.3 Eli Lilly Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 GlaxoSmithKline
  • 7.6.1 GlaxoSmithKline Bioengineered Protein Drugs Production Sites and Area Served
  • 7.6.2 Bioengineered Protein Drugs Product Introduction, Application and Specification
  • 7.6.3 GlaxoSmithKline Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Fresenius Kabi
  • 7.7.1 Fresenius Kabi Bioengineered Protein Drugs Production Sites and Area Served
  • 7.7.2 Bioengineered Protein Drugs Product Introduction, Application and Specification
  • 7.7.3 Fresenius Kabi Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Hoffman-la-Roche
  • 7.8.1 Hoffman-la-Roche Bioengineered Protein Drugs Production Sites and Area Served
  • 7.8.2 Bioengineered Protein Drugs Product Introduction, Application and Specification
  • 7.8.3 Hoffman-la-Roche Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Johnson & Johnson
  • 7.9.1 Johnson & Johnson Bioengineered Protein Drugs Production Sites and Area Served
  • 7.9.2 Bioengineered Protein Drugs Product Introduction, Application and Specification
  • 7.9.3 Johnson & Johnson Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Merck
  • 7.10.1 Merck Bioengineered Protein Drugs Production Sites and Area Served
  • 7.10.2 Bioengineered Protein Drugs Product Introduction, Application and Specification
  • 7.10.3 Merck Bioengineered Protein Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served

8 Bioengineered Protein Drugs Manufacturing Cost Analysis

• 8.1 Bioengineered Protein Drugs Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Bioengineered Protein Drugs
• 8.4 Bioengineered Protein Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Bioengineered Protein Drugs Distributors List
• 9.3 Bioengineered Protein Drugs Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Bioengineered Protein Drugs Market Forecast

• 11.1 Global Bioengineered Protein Drugs Production, Revenue Forecast
  • 11.1.1 Global Bioengineered Protein Drugs Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Bioengineered Protein Drugs Price and Trend Forecast (2019-2025)
• 11.2 Global Bioengineered Protein Drugs Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Bioengineered Protein Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Bioengineered Protein Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Bioengineered Protein Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Bioengineered Protein Drugs Production, Revenue Forecast (2019-2025)
• 11.3 Global Bioengineered Protein Drugs Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Bioengineered Protein Drugs Consumption Forecast (2019-2025)
  • 11.3.2 Europe Bioengineered Protein Drugs Consumption Forecast (2019-2025)
  • 11.3.3 China Bioengineered Protein Drugs Consumption Forecast (2019-2025)
  • 11.3.4 Japan Bioengineered Protein Drugs Consumption Forecast (2019-2025)
• 11.4 Global Bioengineered Protein Drugs Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Bioengineered Protein Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List